An Updated Review on Rheumatoid Arthritis (RA): Epidemiology, Pathophysiology, Diagnosis, and the Current Approaches for Its Treatment
DOI:
https://doi.org/10.18502/sjms.v18i4.14742Keywords:
arthritis, inflammation, joints, quality of life, autoimmunityAbstract
Rheumatoid arthritis (RA) is a systemic self-inflicted inflammatory disease that primarily affects middle-aged women. Globally, 1% of people live with RA. This review aims to provide updated information on the different aspects of RA, including its epidemiology, pathophysiology, diagnosis, treatment, and management. A web-based literature search was conducted through various databases, including PubMed, Google Scholar, and Science Direct, to identify the most relevant studies. Epidemiological studies have suggested that the prevalence and occurrence of RA have remained inconsistent across geographical areas in different periods. Many factors such as age, gender, inheritances, and environmental exposure can contribute to the severity of the disease. The acute form of RA usually presents with pain, and if left untreated, it can result in joint deformities and influence a patient’s quality of life (QoL). RA diagnosis is usually based on the manifestation of pain with inflammation. Currently, many therapeutic strategies are available for the cure of RA. The management of daily routine activities is required with treatment to curtail the damage, avoid future deformities, and ultimately minimize the aching trouble of the patient.
References
Rahimizadeh, P., Rezaieyazdi, Z., Behzadi, F., Hajizade, A., & Lim, S. I. (2021). Nanotechnology as a promising platform for rheumatoid arthritis management: Diagnosis, treatment, and treatment monitoring. International Journal of Pharmaceutics, 609, 121137. https://doi.org/10.1016/j.ijpharm.2021.121137 DOI: https://doi.org/10.1016/j.ijpharm.2021.121137
Aletaha, D., & Smolen, J. S. (2018). Diagnosis and management of rheumatoid arthritis: A review. Journal of the American Medical Association, 320(13), 1360–1372. https://doi.org/10.1001/jama.2018.13103 DOI: https://doi.org/10.1001/jama.2018.13103
Shakil, M., Saleem, D. M., Zafar, A., Ali, A., Raziq, M., & Shams, S. (2021). Clinical and hematological parameters in patients of Rheumatoid arthritis in a tertiary care hospital. Rawal Medical Journal, 46(1), 45–45.
Khaliq, T., Khan, A., & Malik, I. A. (2020). Clinical profile and treatment outcomes of patients with rheumatoid arthritis at a tertiary care hospital of Pakistan. JPMA. The Journal of the Pakistan Medical Association, 70, 1143–1149. https://doi.org/10.5455/JPMA.289952 DOI: https://doi.org/10.5455/JPMA.289952
Mittinty, M. M., Elliott, J. M., Hunter, D. J., Nicholas, M. K., March, L. M., & Mittinty, M. N. (2022). Explaining the gap in the experience of depression among arthritis patients. Clinical Rheumatology, 41(4), 1227–1233. https://doi.org/10.1007/s10067-021-06010-0 DOI: https://doi.org/10.1007/s10067-021-06010-0
Ashiq, K., Rehman, K., Ashiq, S., & Ahlam, S. (2017). Influence of osteoporosis on quality of life and current strategies for its management and treatment. GSC Biological and Pharmaceutical Sciences, 1(2), 34– 40.https://doi.org/10.30574/gscbps.2017.1.2.0051 DOI: https://doi.org/10.30574/gscbps.2017.1.2.0051
Yerima, A., Akintayo, R., & Adebajo, A. (2021). Implications of a diagnosis of rheumatoid arthritis in resource-poor countries. Best Practice & Research Clinical Rheumatology. https://doi.org/10.1016/j.berh.2021.101725 DOI: https://doi.org/10.1016/j.berh.2021.101725
Clayton, S. A., MacDonald, L., Kurowska-Stolarska, M., & Clark, A. R. (2021). Mitochondria as key players in the pathogenesis and treatment of rheumatoid arthritis. Frontiers in Immunology, 12, 1488. https://doi.org/10.3389/fimmu.2021.673916 DOI: https://doi.org/10.3389/fimmu.2021.673916
McInnes, I. B., & Schett, G. (2017). Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet, 389(10086), 2328–2337. https://doi.org/10.1016/S0140- 6736(17)31472-1 DOI: https://doi.org/10.1016/S0140-6736(17)31472-1
Mueller, A. L., Payandeh, Z., Mohammadkhani, N., Mubarak, S. M. H., Zakeri, A., Alagheband Bahrami, A., Brockmueller, A., & Shakibaei, M. (2021). Recent advances in understanding the pathogenesis of rheumatoid arthritis: New treatment strategies. Cells, 10(11), 3017. https://doi.org/10.3390/cells10113017 DOI: https://doi.org/10.3390/cells10113017
Tobón, G. J., Youinou, P., & Saraux, A. (2010). The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis. Autoimmunity Reviews, 9(5), A288– A292. https://doi.org/10.1016/j.autrev.2009.11.019 DOI: https://doi.org/10.1016/j.autrev.2009.11.019
Otón, T., & Carmona, L. (2019). The epidemiology of established rheumatoid arthritis. Best Practice & Research. Clinical Rheumatology, 33(5), 101477. https://doi.org/10.1016/j.berh.2019.101477 DOI: https://doi.org/10.1016/j.berh.2019.101477
Podgórska, D., Cieśla, M., Kolarz, B. (2022). FCER1G gene hypomethylation in patients with rheumatoid arthritis. Journal of Clinical Medicine, 11(16), 4664. DOI: https://doi.org/10.3390/jcm11164664
Fang, Q., Ou, J., & Nandakumar, K. S. (2019). Autoantibodies as diagnostic markers and mediator of joint inflammation in arthritis. Mediators of Inflammation, 2019, 6363086. Advance online publication. https://doi.org/10.1155/2019/6363086 DOI: https://doi.org/10.1155/2019/6363086
Harre, U., Lang, S. C., Pfeifle, R., Rombouts, Y., Frühbeißer, S., Amara, K., Bang, H., Lux, A., Koeleman, C. A., Baum, W., Dietel, K., Gröhn, F., Malmström, V., Klareskog, L., Krönke, G., Kocijan, R., Nimmerjahn, F., Toes, R. E., Herrmann, M., . . . Schett, G. (2015). Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss. Nature Communications, 6(1), 6651. https://doi.org/10.1038/ncomms7651 DOI: https://doi.org/10.1038/ncomms7651
Burmester, G. R., Feist, E., & Dörner, T. (2014). Emerging cell and cytokine targets in rheumatoid arthritis. Nature Reviews Rheumatology, 10(2), 77–88. https://doi.org/10.1038/nrrheum.2013.168 DOI: https://doi.org/10.1038/nrrheum.2013.168
McInnes, I. B., Buckley, C. D., & Isaacs, J. D. (2016). Cytokines in rheumatoid arthritis – Shaping the immunological landscape. Nature Reviews Rheumatology, 12(1), 63–68. https://doi.org/10.1038/nrrheum.2015.171 DOI: https://doi.org/10.1038/nrrheum.2015.171
Fang, Q., Zhou, C., & Nandakumar, K. S. (2020). Molecular and cellular pathways contributing to joint damage in rheumatoid arthritis. Mediators of Inflammation, 2020, 3830212. Advance online publication. https://doi.org/10.1155/2020/3830212 DOI: https://doi.org/10.1155/2020/3830212
Tuna, H. I., Alparslan, G. B., & Yilmaz, S. (2022). Pain and affected symptoms of patients with rheumatoid arthritis during COVID-19 period. Pain Management Nursing, 23(1), 43–47. https://doi.org/10.1016/j.pmn.2021.08.004 DOI: https://doi.org/10.1016/j.pmn.2021.08.004
Chancay, M. G., Guendsechadze, S. N., & Blanco, I. (2019). Types of pain and their psychosocial impact in women with rheumatoid arthritis. Women’s Midlife Health, 5(1), 3. https://doi.org/10.1186/s40695-019-0047-4 DOI: https://doi.org/10.1186/s40695-019-0047-4
Kaptoge, S., Di Angelantonio, E., Pennells, L., Wood, A. M., White, I. R., Gao, P., Walker, M., Thompson, A., Sarwar, N., Caslake, M., Butterworth, A. S., Amouyel, P., Assmann, G., Bakker, S. J., Barr, E. L., Barrett-Connor, E., Benjamin, E. J., Björkelund, C., Brenner, H., . . . Danesh, J., & the Emerging Risk Factors Collaboration. (2012). C-reactive protein, fibrinogen, and cardiovascular disease prediction. The New England Journal of Medicine, 367(14), 1310–1320. https://doi.org/10.1056/NEJMoa1107477 DOI: https://doi.org/10.1056/NEJMoa1107477
Kaushik, P., Solomon, D. H., Greenberg, J. D., Anderson, J. T., Reed, G., Pala, O., Sumbul-Yuksel, B., Kadam, P., Kremer, J. M., & the CORRONA investigators. (2015). Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: Results from a large US registry. Clinical Rheumatology, 34(10), 1697–1704. https://doi.org/10.1007/s10067-015-3032-9 DOI: https://doi.org/10.1007/s10067-015-3032-9
Lin, Y. J., Anzaghe, M., & Schülke, S. (2020). Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells, 9(4), 880. https://doi.org/10.3390/cells9040880 DOI: https://doi.org/10.3390/cells9040880
do Prado, A. D., Staub, H. L., Bisi, M. C., da Silveira, I. G., Mendonça, J. A., Polido- Pereira, J., & Fonseca, J. E. (2018). Ultrasound and its clinical use in rheumatoid arthritis: Where do we stand? Advances in Rheumatology (London, England), 58, 19. Advance online publication. https://doi.org/10.1186/s42358-018-0023-y DOI: https://doi.org/10.1186/s42358-018-0023-y
Takase-Minegishi, K., Horita, N., Kobayashi, K., Yoshimi, R., Kirino, Y., Ohno, S., Kaneko, T., Nakajima, H., Wakefield, R. J., & Emery, P. (2018). Diagnostic test accuracy of ultrasound for synovitis in rheumatoid arthritis: Systematic review and meta-analysis. Rheumatology (Oxford, England), 57(1), 49–58. https://doi.org/10.1093/rheumatology/kex036 DOI: https://doi.org/10.1093/rheumatology/kex036
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., III, Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., Combe, B., Costenbader, K. H., Dougados, M., Emery, P., Ferraccioli, G., Hazes, J. M., Hobbs, K., Huizinga, T. W., Kavanaugh, A., . . . Hawker, G. (2010). 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis and Rheumatism, 62(9), 2569– 2581. https://doi.org/10.1002/art.27584 DOI: https://doi.org/10.1002/art.27584
Akram, M., Daniyal, M., Sultana, S., Owais, A., Akhtar, N., Zahid, R., Said, F., Bouyahya, A., Ponomarev, E., Ali Shariat, M., & Thiruvengadam, M. (2021). Traditional and modern management strategies for rheumatoid arthritis. Clinica Chimica Acta, 512, 142–155. https://doi.org/10.1016/j.cca.2020.11.003 DOI: https://doi.org/10.1016/j.cca.2020.11.003
Ruffer, N., Krusche, M., Beil, F. T., Amling, M., Kötter, I., & Rolvien, T. (2022). Clinical features of methotrexate osteopathy in rheumatic musculoskeletal disease: A systematic review. Seminars in Arthritis and Rheumatism, 52, 151952. https://doi.org/10.1016/j.semarthrit.2022.151952 DOI: https://doi.org/10.1016/j.semarthrit.2022.151952
Paglia, M. D. G., Silva, M. T., Lopes, L. C., Barberato-Filho, S., Mazzei, L. G., Abe, F. C., & de Cássia Bergamaschi, C. (2021). Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review and network meta-analysis. PLoS One, 16(4), e0248866. https://doi.org/10.1371/journal.pone.0248866 DOI: https://doi.org/10.1371/journal.pone.0248866
Hua, C., Buttgereit, F., & Combe, B. (2020). Glucocorticoids in rheumatoid arthritis: Current status and future studies. RMD Open, 6(1), e000536. https://doi.org/10.1136/rmdopen-2017-000536 DOI: https://doi.org/10.1136/rmdopen-2017-000536
Ashiq, K., Bajwa, M. A., Khokhar, R., Abid, F., Tanveer, S., Qayyum, M., Ashiq, S., & Jameel, S. (2022). A Cross-sectional analysis of knowledge, beliefs and practices regarding traditional medicine use among pharmacy students of different private and government universities of Lahore, Pakistan. Bangladesh Journal of Medical Science, 21(2), 323–334. https://doi.org/10.3329/bjms.v21i2.58065 DOI: https://doi.org/10.3329/bjms.v21i2.58065
Chaudhary, A., & Vinay, P. (2020). Rheumatoid arthritis: Etiology, treatment and animal models. Journal of Drug Delivery and Therapeutics, 10(no. 5-s), 290–298. https://doi.org/10.22270/jddt.v10i5-s.4357 DOI: https://doi.org/10.22270/jddt.v10i5-s.4357
Sarsenova, M., Issabekova, A., Abisheva, S., Rutskaya-Moroshan, K., Ogay, V., & Saparov, A. (2021). Mesenchymal stem cell-based therapy for rheumatoid arthritis. International Journal of Molecular Sciences, 22(21), 11592. https://doi.org/10.3390/ijms222111592 DOI: https://doi.org/10.3390/ijms222111592
Ashiq, K., Bajwa, M. A., Tanveer, S., Qayyum, M., Ashiq, S., Khokhar, R., & Abid, F. (2021). A comprehensive review on gout: The epidemiological trends, pathophysiology, clinical presentation, diagnosis and treatment. JPMA. The Journal of the Pakistan Medical Association, 71(4), 1234–1238. https://doi.org/10.47391/JPMA.313 DOI: https://doi.org/10.47391/JPMA.313
Babar, Z. U. D. (2022). Forming a medicines pricing policy for low and middleincome countries (LMICs): The case for Pakistan. Journal of Pharmaceutical Policy and Practice, 15(1), 9. https://doi.org/10.1186/s40545-022-00413-3 DOI: https://doi.org/10.1186/s40545-022-00413-3
